Pharmaceutical - Mergers & Acquisitions, Nephrology and Hepatology


Popular Filters

Shire acquires Fibrotech for $75 million

Shire acquires Fibrotech for $75 million


Ireland-headquartered drugmaker Shire has acquired Australian biopharmaceutical company Fibrotech for…

AustraliaFibrotechFocal segmental glomerulosclerosisGlomerulosclerosisHead of research and developmentIrelandKidney diseasesMergers & AcquisitionsNephrology and HepatologyPharmaceuticalPhil VickersShire

Italy’s Gentium accepts $1 billion takeover offer from Jazz Pharma


Ireland-headquartered drugmaker Jazz Pharmaceuticals has entered into a definitive agreement to acquire…

defibrotideDefitelioGentiumItalyJazz PharmaceuticalsMergers & AcquisitionsNephrology and HepatologyPharmaceuticalRare diseases

OPKO Health inks deal to acquire Cytochroma and two Ph III products


Privately-held Canadian company Cytochroma says that it has entered into a definitive agreement to be…

AlpharenCytochromaMergers & AcquisitionsNephrology and HepatologyOPKO HealthPharmaceuticalReplidea

Baxter to expand renal therapies range with $4 billion buy of Gambro


Confirming recent rumors and speculation, Baxter International (NYSE:BAX ) said yesterday it has entered…

Baxter InternationalGambroMergers & AcquisitionsNephrology and HepatologyPharmaceutical

Amgen and KPCB to create Atara Biotherapeutics; Banner Pharmacaps changes hands


The world's largest biotech firm Amgen (Nasdaq: AMGN) and venture capital group Kleiner Perkins Caufield…

AmgenAtara BiotherapeuticsBanner PharmacapsBiotechnologyLicensingMergers & AcquisitionsNephrology and HepatologyOncologyPatheonPharmaceuticalProduction

Company Spotlight



Back to top